Dr. Priya Kathpalia, MD

Dr. Kathpalia practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Kathpalia's NPI, 1194046821, was assigned on June 16, 2010. Dr. Kathpalia graduated from Loyola University of Chicago, Stritch School of Medicine in 2010. Dr. Kathpalia holds California license A130316.

Dr. Kathpalia's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Kathpalia's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Kathpalia is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Kathpalia to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kathpalia practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kathpalia's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Kathpalia's licenses on file in 2 states: California and Illinois.

CMS data shows 937 Medicare services from Dr. Kathpalia across 17 procedure codes in 2024, for 447 Medicare patients. Medicare paid $85,237 for them.

CMS counts 447 Medicare patients who saw Dr. Kathpalia in 2024. The largest group is 65 to 74, with 228 patients. 69% of them have high cholesterol, and 62% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kathpalia's median patient age at 64, with 56% women.

In 2024, Dr. Kathpalia wrote 191 Medicare Part D claims for 78 patients. 91% of them were for generic drugs. CMS names the drug for 137 of them, across 4 drugs with 11 or more claims each, at $3,600 in total drug cost. In 2023, CMS named 35 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kathpalia for performance year 2024, reported as part of a group. Dr. Kathpalia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kathpalia as offering telehealth. CMS counts 111 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kathpalia, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Kathpalia, published from 2014 to 2024. 2016 was the busiest year, with 3. The most frequent topics are Gastroesophageal Reflux, Quality Indicators, Health Care and Clinical Competence. Dr. Kathpalia has published most often in Am J Gastroenterol. Dr. Kathpalia's most frequent co-authors are Fouad Otaki, MD, John E. Pandolfino, MD and David A. Katzka, MD.

CMS Open Payments shows 35 general payments to Dr. Kathpalia from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $4,073.

Dr. Kathpalia graduated from Loyola University of Chicago, Stritch School of Medicine in 2010.